Basic Information
RNALocate ID: | RLID:01001196 |
RNA Symbol: | hsa-let-7b-5p |
Localization: | Cytoplasm |
RNA Information
RNA Name: | hsa-let-7b |
RNA ID: | miRBase:MIMAT0000063 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21695135 |
Tissue/Cell Line: | Cell line (HeLa) |
Method: | Microarray |
Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA. Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001195 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001197 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001198 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001199 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
RLID:01001200 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
RLID:01001201 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001202 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001203 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001204 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001205 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001206 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:01001207 | Nucleus | HeLa cells | 22058130 |
RLID:11000572 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11000573 | Exosome | Healthy donor seminal fluid|Ovarian carcinoma cells (2008 cell line) | 25267620 |
RLID:11000574 | Exosome | Pooled sera | 27278097 |
RLID:11000575 | Exosome | Saliva | 19627513 |
RLID:11000576 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11000577 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000578 | Exosome | Primary dendritic cells | 21505438 |
RLID:11000579 | Exosome | Renal cancer cells | 21670082 |
RLID:11000580 | Exosome | Epidermal melanocytes (HEMa-LP) | 23056502 |
RLID:11000581 | Exosome | Saliva | 23302638 |
RLID:11000582 | Exosome | Brain tissue | 23382797 |
RLID:11000583 | Exosome | Plasma | 23663360 |
RLID:11000584 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000585 | Exosome | Urine | 25135963 |
RLID:11000586 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11000587 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11000588 | Microvesicle | Glioma cell line (U251) | 23807490 |
RLID:11000589 | Microvesicle | Plasma | 19002258 |
RLID:11000590 | Microvesicle | Plasma | 23077538 |
RLID:11000591 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000592 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000593 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000002 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Mast cells|Saliva|Seminal fluid|Tongue tissue | |
RLID-D:11000262 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-00733 |
MNDR | hsa-let-7b-5p | Oral squamous cell carcinoma | MNDR-E-MI-00734 |
MNDR | hsa-let-7b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-00735 |
MNDR | hsa-let-7b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-00736 |
MNDR | hsa-let-7b-5p | Lymphoma | MNDR-E-MI-00737 |
MNDR | hsa-let-7b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-00738 |
MNDR | hsa-let-7b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-00739 |
MNDR | hsa-let-7b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-00740 |
MNDR | hsa-let-7b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-00741 |
MNDR | hsa-let-7b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-00742 |
MNDR | hsa-let-7b-5p | Prostate cancer | MNDR-E-MI-00743 |
MNDR | hsa-let-7b-5p | Gastric cancer | MNDR-E-MI-00744 |
MNDR | hsa-let-7b-5p | Gastric lymphoma | MNDR-E-MI-00745 |
MNDR | hsa-let-7b-5p | Alzheimer disease | MNDR-E-MI-00746 |
MNDR | hsa-let-7b-5p | Dysautonomia familial | MNDR-E-MI-00747 |
MNDR | hsa-let-7b-5p | Leukemia | MNDR-E-MI-00748 |
MNDR | hsa-let-7b-5p | Cardiovascular disease | MNDR-E-MI-00749 |
MNDR | hsa-let-7b-5p | Lung cancer | MNDR-E-MI-00750 |
MNDR | hsa-let-7b-5p | Metabolic syndrome x | MNDR-E-MI-00751 |
MNDR | hsa-let-7b-5p | Parkinson disease | MNDR-E-MI-00752 |
MNDR | hsa-let-7b-5p | Breast cancer | MNDR-E-MI-00753 |
MNDR | hsa-let-7b-5p | Thyroid cancer | MNDR-E-MI-00754 |
MNDR | hsa-let-7b-5p | Pancreatic cancer | MNDR-E-MI-00755 |
MNDR | hsa-let-7b-5p | Melanoma | MNDR-E-MI-00756 |
MNDR | hsa-let-7b-5p | Rectum adenocarcinoma | MNDR-E-MI-00757 |
MNDR | hsa-let-7b-5p | Nephroblastoma | MNDR-E-MI-00758 |
MNDR | hsa-let-7b-5p | Colon cancer | MNDR-E-MI-00759 |
MNDR | hsa-let-7b-5p | Colon adenocarcinoma | MNDR-E-MI-00760 |
MNDR | hsa-let-7b-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-00761 |
MNDR | hsa-let-7b-5p | Familial ovarian cancer | MNDR-E-MI-00762 |
MNDR | hsa-let-7b-5p | Prostate adenocarcinoma | MNDR-E-MI-00763 |
MNDR | hsa-let-7b-5p | Carcinoma ductal breast | MNDR-E-MI-00764 |
MNDR | hsa-let-7b-5p | Glioblastoma | MNDR-E-MI-00765 |
MNDR | hsa-let-7b-5p | Glioma | MNDR-E-MI-00766 |
MNDR | hsa-let-7b-5p | Chordoma | MNDR-E-MI-00767 |
MNDR | hsa-let-7b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-00768 |
MNDR | hsa-let-7b-5p | Temporal lobe epilepsy | MNDR-E-MI-00769 |
MNDR | hsa-let-7b-5p | Liposarcoma | MNDR-E-MI-00770 |
MNDR | hsa-let-7b-5p | Liver cancer | MNDR-E-MI-00771 |
MNDR | hsa-let-7b-5p | Uterine cancer | MNDR-E-MI-00772 |
MNDR | hsa-let-7b-5p | Gastric adenocarcinoma | MNDR-E-MI-00773 |
MNDR | hsa-let-7b-5p | Lung squamous cell carcinoma | MNDR-E-MI-00774 |
MNDR | hsa-let-7b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-00775 |
MNDR | hsa-let-7b-5p | Lung adenocarcinoma | MNDR-E-MI-00776 |
MNDR | hsa-let-7b-5p | Thyroid carcinoma | MNDR-E-MI-00777 |
MNDR | hsa-let-7b-5p | Tuberculosis | MNDR-E-MI-00778 |
MNDR | hsa-let-7b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-00779 |
MNDR | hsa-let-7b-5p | Carcinoma renal cell | MNDR-E-MI-00780 |
MNDR | hsa-let-7b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-00781 |
MNDR | hsa-let-7b-5p | Renal clear cell carcinoma | MNDR-E-MI-00782 |
MNDR | hsa-let-7b-5p | Large cell carcinoma | MNDR-E-MI-00783 |
MNDR | hsa-let-7b-5p | Biliary tract cancer | MNDR-E-MI-00784 |
MNDR | hsa-let-7b-5p | Cholangiocarcinoma | MNDR-E-MI-00785 |
MNDR | hsa-let-7b-5p | Esophageal cancer | MNDR-E-MI-00786 |
MNDR | hsa-let-7b-5p | Liver cirrhosis | MNDR-E-MI-00787 |
MNDR | hsa-let-7b-5p | Fibromyalgia | MNDR-E-MI-00788 |
MNDR | hsa-let-7b-5p | Adenoma | MNDR-E-MI-00789 |
MNDR | hsa-let-7b-5p | Breast invasive carcinoma | MNDR-E-MI-00790 |
MNDR | hsa-let-7b-5p | Early hepatocellular carcinoma | MNDR-E-MI-00791 |
MNDR | hsa-let-7b-5p | Familiar ovarian carcinoma | MNDR-E-MI-00792 |
MNDR | hsa-let-7b-5p | B-cell lymphoma | MNDR-E-MI-00793 |
MNDR | hsa-let-7b-5p | Rheumatoid arthritis | MNDR-E-MI-00794 |
MNDR | hsa-let-7b-5p | T-cell leukemia | MNDR-E-MI-00795 |
MNDR | hsa-let-7b-5p | Retinoblastoma | MNDR-E-MI-00796 |
MNDR | hsa-let-7b-5p | Neuroblastoma | MNDR-E-MI-00797 |
MNDR | hsa-let-7b-5p | Hodgkin lymphoma | MNDR-E-MI-00798 |
MNDR | hsa-let-7b-5p | Burkitt lymphoma | MNDR-E-MI-00799 |
MNDR | hsa-let-7b-5p | Colorectal cancer | MNDR-E-MI-00800 |
MNDR | hsa-let-7b-5p | Nasopharynx carcinoma | MNDR-E-MI-00801 |
MNDR | hsa-let-7b-5p | Multiple myeloma | MNDR-E-MI-00802 |
MNDR | hsa-let-7b-5p | Ependymoma | MNDR-E-MI-00803 |
MNDR | hsa-let-7b-5p | Nasopharyngeal cancer | MNDR-E-MI-00804 |
MNDR | hsa-let-7b-5p | Prostatic neoplasms | MNDR-E-MI-00805 |
MNDR | hsa-let-7b-5p | Breast cancer her3+ negative | MNDR-E-MI-00806 |
MNDR | hsa-let-7b-5p | High grade dysplastic nodule | MNDR-E-MI-00807 |
MNDR | hsa-let-7b-5p | Tubulovillous adenoma | MNDR-E-MI-00808 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACTG1 | Homo sapiens | RR00037114 |
TOP